CAR- T as well as mobile genetics therapies are too costly

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and modern technology transactions can easily supply mobile gene treatments at a cost effective cost to people around the world.